SCM
ALXN

Sio Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Sio Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-37,781
Closed -$4.09M – 98
2019
Q4 		$4.09M Sell
37,781
-13,500
-26% -$1.44M 0.97% 28
2019
Q3 		$5.02M Sell
51,281
-20,240
-28% -$2.28M 1.62% 23
2019
Q2 		$9.37M Buy
71,521
+36,100
+102% +$4.65M 2.26% 11
2019
Q1 		$4.79M Buy
35,421
+18,421
+108% +$2.29M 1.29% 28
2018
Q4 		$1.66M Sell
17,000
-8,785
-34% -$1.04M 0.6% 52
2018
Q3 		$3.58M Buy
+25,785
New +$3.23M 1.23% 30

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sio Capital Management's ALXN Position: Q1 2020 in Review

Sio Capital Management sold out of Alexion Pharmaceuticals (ALXN) in Q1 2020, closing a stake of 37,781 shares — an estimated $4.09M sold.

Sio Capital Management first reported a position in ALXN in Q3 2018 and held it in 6 quarters. The position peaked at $9.37M in Q2 2019. 654 funds tracked by Wall St. Rank hold ALXN as of Q1 2020.

  • Sio Capital Management reported no remaining Alexion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Sio Capital Management sold 37,781 Alexion Pharmaceuticals shares in Q1 2020, an estimated $4.09M.
  • Sio Capital Management first reported a position in Alexion Pharmaceuticals in Q3 2018 and held it in 6 quarters.
  • Sio Capital Management's Alexion Pharmaceuticals position peaked at $9.37M in Q2 2019.
  • 654 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2020.

Based on Sio Capital Management's 13F filing for Q1 2020, filed 15 May 2020.